Baudax Bio, Inc.
Intranasal dexmedetomidine compositions and methods of use thereof
Last updated:
Abstract:
The present invention provides intranasal formulations comprising dexmedetomidine, or a pharmaceutically acceptable salt thereof, and uses thereof.
Status:
Grant
Type:
Utility
Filling date:
12 Sep 2017
Issue date:
16 Jun 2020